Cargando…
ICER publishes draft scoping report on COVID-19 treatments
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413704/ https://www.ncbi.nlm.nih.gov/pubmed/34493919 http://dx.doi.org/10.1007/s40274-021-08009-4 |
Ejemplares similares
-
ICER update to pricing models of remdesivir for COVID-19
Publicado: (2020) -
ICER's timelines for assessments extended due to COVID-19
Publicado: (2020) -
ICER's second update to pricing models of remdesivir for COVID-19
Publicado: (2020) -
ICER releases evidence report on elexacaftor/tezacaftor/ivacaftor for cystic fibrosis
Publicado: (2020) -
NICE to publish guidelines for rare blood clotting syndrome from COVID-19 vaccination
Publicado: (2021)